FMS: Fresenius Medical EV/EBITDA Multiple
German dialysis leader Fresenius Medical Care (FMS) is protected by its humanitarian status, which minimizes geopolitical risks. Stable demand for life-sustaining procedures allows the company to exercise pricing power over private insurers. The business is currently focusing on cost restructuring and margin expansion. The GURU.Markets system identifies a valuation trend based on EV/EBITDA, where 5.60 is the current value of the metric.
Analytical breakdowns for Fresenius Medical Care
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- debt burden and liquidity indicators:
Debt to Equity Fresenius Medical Care|FMS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Fresenius Medical Care AG & Co. KGaA|FMS - Company Cumulative Debt|Debt to Book Capitalization Ratio Fresenius Medical|FMS - Company Long-Term Indebtedness|Company Short-Term Debts Fresenius Medical Care|Quick Liquidity Indicator freseniusmedicalcare.com
- business earnings and investment ratios data:
FMS - Net Profit|Expected Profit Fresenius Medical Care|FMS - Business Payback Period|Projected Price to Earnings Fresenius Medical Care|FMS - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Fresenius Medical|FMS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Fresenius Medical Care|FMS - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth freseniusmedicalcare.com|FMS - Earnings per share growth this year|Earnings growth forecast for next year Fresenius Medical Care
Initial company analysis:FMS (Fresenius Medical Care Corp)
The EV/EBITDA multiple determines the enterprise value including debt relative to operating profit, allowing for an assessment of the real value of assets without the influence of tax policy. For Fresenius Medical Care (FMS), this indicator reflects the efficiency of the capital-intensive infrastructure of dialysis centers and logistics chains. By analyzing the change in the EV/EBITDA value over time, an investor can see the correlation between the debt load and the profitability of the service. A stable range for this metric confirms the resilience of the company's fundamental value.
Competitor analysis for Fresenius Medical Care
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|Solventum Corporation - EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio EHC|uhsinc.com (UHS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DaVita HealthCare Partners - Business Value to Operating Income Before Depreciation|RDNT (RadNet Corp) - EV/EBITDA Multiple|Company Value to EBITDA Option Care Corp OPCH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surgery Partners, Inc. (SGRY)|Total Company Value to Operating Income Before Depreciation Ratio premierinc.com|EV/EBITDA Multiple EYE (National Vision)|Progyny Inc (PGNY) - Company Value to EBITDA|ARDT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEM (Select Medical Inc.) - Enterprise Value to Operating Income Before Depreciation|ASTH: EV/EBITDA Multiple|MD - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio USPH|EV/EBITDA Multiple Pennant Group|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Organogenesis Inc. (ORGO)|Total Company Value to Operating Income Before Depreciation Ratio Nutex Health Hospitals|Auna SA - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SBC|EOLS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CHS (CYH) - Enterprise Value to EBITDA Ratio|SKIN: EV/EBITDA Multiple|Company Value to EBITDA MediWound (MDWD)|BTMD (biote Corp.) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation JYNT (thejoint.com)|EV/EBITDA Multiple DCGO|Total Company Value to Operating Income Before Depreciation Ratio p3hp.org|EV/EBITDA Multiple GANX (Gain Therapeutics, Inc.)|EUDA - Enterprise Value to EBITDA Ratio|Basel Medical Group Limited - EV/EBITDA Multiple|CLGN - EV/EBITDA Multiple|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CCM (Concord Medical Services Holdings) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio AMS|MRM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALBT|Enterprise Value to EBITDA Ratio dih.com DHAI|EV/EBITDA Multiple XAGE (Carmell Therapeutics)|EV/EBITDA Multiple NewGenIvf Group NIVF|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CMAX (CareMax, Inc)|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|SunLink Health Systems, Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
